All results
1 results for phase 2 clinical trial patients metastatic neuroblastoma bone
-
PNOC020:RNA-Lipid Particle Vaccines for Newly Diagnosed Ped HGG and Adult GBM
The primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in…
- Ages
- 21 Years - N/A
- Sexes
- All